Application form: tablets, capsules
Indication group: expectorants, mucolytics
Active substance: Ambroxoli hydrochloridum 30 mg
minimum amount for dispatch: Mucosolvan : ambroxol, Mucosolvan preparation active substance, increases phlegm secretion in the respiratory tract, pulmonary surfactant (substance covering the internal wall of the air sacks) production and stimulates activity of the basal corpuscles providing phlegm movement. These effects result in more movement liquefaction, better transport and phlegm excreting (mucociliar clearance), by which expectoration is easier and cough is moderated.
Manufacturer: Boehringer Ingelheim Pharma GmbH. KG, Ingelheim am Rhein, Germany, www.boehringer-ingelheim.com